Sander Markx

2.3k total citations
22 papers, 1.3k citations indexed

About

Sander Markx is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Sander Markx has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Genetics and 3 papers in Neurology. Recurrent topics in Sander Markx's work include Congenital heart defects research (9 papers), Genomic variations and chromosomal abnormalities (4 papers) and Autoimmune Neurological Disorders and Treatments (3 papers). Sander Markx is often cited by papers focused on Congenital heart defects research (9 papers), Genomic variations and chromosomal abnormalities (4 papers) and Autoimmune Neurological Disorders and Treatments (3 papers). Sander Markx collaborates with scholars based in United States, Netherlands and Canada. Sander Markx's co-authors include Joseph A. Gogos, Josep Dalmau, Bin Xu, Kevin A. Strauss, Steven A. Kushner, Maria Karayiorgou, Jonathan A. Javitch, Eugenia Martínez‐Hernández, Elior Peles and Isabel Illa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Neuroscience.

In The Last Decade

Sander Markx

21 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sander Markx United States 14 558 417 403 280 194 22 1.3k
Lorenzo Sinibaldi Italy 20 447 0.8× 509 1.2× 139 0.3× 284 1.0× 414 2.1× 46 1.5k
Anthony Simone United States 6 944 1.7× 236 0.6× 127 0.3× 339 1.2× 158 0.8× 9 1.4k
Shani Stern Israel 19 660 1.2× 365 0.9× 71 0.2× 284 1.0× 165 0.9× 50 1.2k
Ozama Ismail United Kingdom 14 366 0.7× 120 0.3× 394 1.0× 792 2.8× 140 0.7× 26 1.5k
Maria T. Acosta United States 20 386 0.7× 253 0.6× 403 1.0× 163 0.6× 333 1.7× 63 1.3k
Mihovil Pletikos United States 18 680 1.2× 358 0.9× 78 0.2× 297 1.1× 458 2.4× 21 1.8k
David Matzilevich United States 10 551 1.0× 186 0.4× 111 0.3× 285 1.0× 134 0.7× 11 1.1k
Stephen C. Harward United States 15 302 0.5× 78 0.2× 236 0.6× 475 1.7× 191 1.0× 31 1.1k
Michael A. Schmidt United States 18 487 0.9× 519 1.2× 149 0.4× 48 0.2× 266 1.4× 37 1.2k
Azlina Ahmad‐Annuar Malaysia 16 540 1.0× 220 0.5× 399 1.0× 383 1.4× 79 0.4× 69 1.3k

Countries citing papers authored by Sander Markx

Since Specialization
Citations

This map shows the geographic impact of Sander Markx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sander Markx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sander Markx more than expected).

Fields of papers citing papers by Sander Markx

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sander Markx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sander Markx. The network helps show where Sander Markx may publish in the future.

Co-authorship network of co-authors of Sander Markx

This figure shows the co-authorship network connecting the top 25 collaborators of Sander Markx. A scholar is included among the top collaborators of Sander Markx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sander Markx. Sander Markx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lackinger, Martin, Anastasia Diamantopoulou, Yijing Chen, et al.. (2025). An antisense oligonucleotide-based strategy to ameliorate cognitive dysfunction in the 22q11.2 Deletion Syndrome. eLife. 13.
2.
Brundu, Francesco, Yan Sun, Huixiang Zhu, et al.. (2025). Aberrant pace of cortical neuron development in brain organoids from patients with 22q11.2 deletion syndrome-associated schizophrenia. Nature Communications. 16(1). 6986–6986. 2 indexed citations
3.
Finnerty, Molly, Atif Ali Khan, Rui Wang, et al.. (2024). Prevalence and incidence measures for schizophrenia among commercial health insurance and medicaid enrollees. SHILAP Revista de lepidopterología. 10(1). 68–68. 1 indexed citations
4.
Li, Yunfei, Huixiang Zhu, Yan Sun, et al.. (2023). Inhibition of Abl Kinase by Imatinib Can Rescue the Compromised Barrier Function of 22q11.2DS Patient-iPSC-Derived Blood–Brain Barriers. Cells. 12(3). 422–422. 4 indexed citations
5.
Rabadán, M. Angeles, Gregg W. Crabtree, Bin Xu, et al.. (2022). An in vitro model of neuronal ensembles. Nature Communications. 13(1). 3340–3340. 14 indexed citations
6.
Xia, Yifan, Huixiang Zhu, Yan Sun, et al.. (2021). Investigation of Neurodevelopmental Deficits of 22 q11.2 Deletion Syndrome with a Patient-iPSC-Derived Blood–Brain Barrier Model. Cells. 10(10). 2576–2576. 14 indexed citations
7.
Zoghbi, Anthony W., Ryan S. Dhindsa, Terry E. Goldberg, et al.. (2021). High-impact rare genetic variants in severe schizophrenia. Proceedings of the National Academy of Sciences. 118(51). 33 indexed citations
8.
Llapashtica, Ceyda, Matthieu Genestine, Kevin A. Strauss, et al.. (2021). Cortical overgrowth in a preclinical forebrain organoid model of CNTNAP2-associated autism spectrum disorder. Nature Communications. 12(1). 4087–4087. 82 indexed citations
9.
Bouwkamp, Christian G., Anneke J.A. Kievit, Sander Markx, et al.. (2017). Copy Number Variation in Syndromic Forms of Psychiatric Illness: The Emerging Value of Clinical Genetic Testing in Psychiatry. American Journal of Psychiatry. 174(11). 1036–1050. 9 indexed citations
10.
Strauss, Kevin A., Sander Markx, Benjamin Georgi, et al.. (2014). A population-based study of KCNH7 p.Arg394His and bipolar spectrum disorder. Human Molecular Genetics. 23(23). 6395–6406. 39 indexed citations
11.
Ellegood, Jacob, Sander Markx, Jason P. Lerch, et al.. (2013). A highly specific pattern of volumetric brain changes due to 22q11.2 deletions in both mice and humans. Molecular Psychiatry. 19(1). 6–6. 4 indexed citations
12.
Costello, Daniel J., et al.. (2013). Anti-NMDA Receptor Encephalitis. Journal of Psychiatric Practice. 19(2). 157–161. 33 indexed citations
13.
Fénelon, Karine, Bin Xu, Cora Sau Wan Lai, et al.. (2013). The Pattern of Cortical Dysfunction in a Mouse Model of a Schizophrenia-Related Microdeletion. Journal of Neuroscience. 33(37). 14825–14839. 89 indexed citations
14.
Ellegood, Jacob, Sander Markx, Jason P. Lerch, et al.. (2013). Neuroanatomical phenotypes in a mouse model of the 22q11.2 microdeletion. Molecular Psychiatry. 19(1). 99–107. 46 indexed citations
15.
Karam, Caline S., Jacob S. Ballon, Zachary Freyberg, et al.. (2010). Signaling pathways in schizophrenia: emerging targets and therapeutic strategies. Trends in Pharmacological Sciences. 31(8). 381–390. 129 indexed citations
16.
Lancaster, Eric, Maartje G. Huijbers, Vered Bar, et al.. (2010). Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Annals of Neurology. 69(2). 303–311. 323 indexed citations
17.
Arguello, P. Alexander, Sander Markx, Joseph A. Gogos, & Maria Karayiorgou. (2010). Development of animal models for schizophrenia. Disease Models & Mechanisms. 3(1-2). 22–26. 28 indexed citations
18.
Drew, Liam, Gregg W. Crabtree, Sander Markx, et al.. (2010). The 22q11.2 microdeletion: Fifteen years of insights into the genetic and neural complexity of psychiatric disorders. International Journal of Developmental Neuroscience. 29(3). 259–281. 103 indexed citations
19.
Markx, Sander & David Kahn. (2008). An 18-Year-Old Woman with New-Onset Suicidal Ideation While Being Treated with Atomoxetine. Journal of Psychiatric Practice. 14(1). 62–66. 2 indexed citations
20.
Friedman, Joseph I., Terry Vrijenhoek, Sander Markx, et al.. (2007). CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Molecular Psychiatry. 13(3). 261–266. 224 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorenzo Sinibaldi Breakdown of academic impact, for papers by Anthony Simone Breakdown of academic impact, for papers by Shani Stern Breakdown of academic impact, for papers by Ozama Ismail Breakdown of academic impact, for papers by Maria T. Acosta Breakdown of academic impact, for papers by Mihovil Pletikos Breakdown of academic impact, for papers by David Matzilevich Breakdown of academic impact, for papers by Stephen C. Harward Breakdown of academic impact, for papers by Michael A. Schmidt Breakdown of academic impact, for papers by Azlina Ahmad‐Annuar
Rankless by CCL
2026